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Abstract: Brucellosis is considered as endemic disease of animals and humans since thousands of
years in Egypt. However, brucellosis in pigs has never been reported in Egypt. Thus, serological and
molecular assays were applied to detect anti-Brucella antibodies and DNA in serum samples collected
from pigs. In total 331 blood samples collected from male and female pigs at slaughterhouses of Cairo
and Giza governorates were investigated using Brucella c- and i-ELISA and Brucella real-time PCR.
Anti-Brucella antibodies were detected in 16 (4.83%) and 36 (10.8%) sera by i-ELISA and c-ELISA,
respectively. Brucella DNA was detected in 10 (3.02%) seropositive samples and identified as Brucella
melitensis (7/10) and Brucella suis (3/10). A higher prevelance was found in boars. This is the first study
investigating pig brucellosis in Egypt. The results of this study will raise awareness for brucellosis in
these farm animals and will help to develop effective control strategies.
Keywords: brucellosis; swine; Egypt; ELISA; real-time PCR
1. Introduction
Brucellosis is a zoonotic disease of public health importance affecting livestock, wildlife, and
humans globally. The Brucella (B.) genus includes eleven recognized species with varying host
preferences, pathogenicity, and epidemiology [1,2]. The disease is well controlled in developed
countries but is still endemic in many others with the highest records in humans in Middle East and
Central Asian regions [3].
Brucellosis is one of the major livestock production constraints in Egypt [4]. It is likely that it has
been endemic in Egypt for thousands of years [5,6]. The disease has been detected with increasing
prevalence in livestock species but predominantly in ruminants [7,8]. Prevalences ranging from 2.47%
to 26.66% were found in various animal populations [9]. Brucella abortus and B. melitensis were isolated
from livestock and humans and B. suis was identified in cattle [6,10]. Brucellosis proved to be a serious
occupational health hazard to livestock handlers, especially abattoir workers in Egypt [11].
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World pig production has increased fourfold over the last five decades to meet protein requirements
globally and is expected to continue growing [12]. Production of pigs in Egypt is found primarily
in slums, rural, and per-urban areas especially in Cairo and Giza governorates. Pork is consumed
by Christians, foreigners, and tourists in Egypt. Currently the pig population is around two to three
millions [13,14]. In Egypt, pigs are kept in small groups in contact with other farm animals and humans
sharing pathogens with each other [15].
Typically, the infection is caused by B. suis biovars 1–3 [16]. The disease occurs in many countries
where pigs are raised. Generally, the prevalence is low, but in some parts of the world, especially in
the Southeast Asia and the South America, the prevalence may be much higher. B. suis bv1 infection
has been reported in feral pigs in some parts of the southern states of USA and in Queensland,
Australia. In these regions, a number of human brucellosis cases have been reported in hunters and
handlers of materials of feral pigs. B. suis bv2 outbreaks have also been reported in Europe in wild
boars, which were implicated in transmission of B. suis bv2 to domestic outdoor pigs [2]. Human
pathogenic biovars (B. suis biovar 1–4) pose a sever hazard to humans [16]. Hence, B. abortus [17,18]
and B. melitensis [19,20] were also isolated from pigs when kept together with infected ruminants
and camels.
Brucellosis in pigs is a contagious disease characterized by infertility, production of small litters,
and abortion in sows and orchitis and infection of secondary sex organs in boars [21]. The clinical
manifestations are not pathognomonic. A diagnosis of brucellosis can be made mainly by the isolation
and identification of Brucella, but in situations where bacteriological examination is not practicable,
diagnosis should be based on immunological methods [2]. Serological tests are preferred for screening
as they are comparatively sensitive and specific compared to bacterial cultivation to minimize the risk
of laboratory acquired infections [2].
“Pig” brucellosis in humans is frequently a disease of slaughterhouse workers, farmers,
and veterinarians [16]. Direct contact with infected animals or aborted materials may lead to human
infection. In humans, brucellosis is generally a chronic illness manifested by intermittent fever, malaise,
night sweats, and musculoskeletal and neurological signs [2,16].
For serological testing various tests, usually a screening test of high sensitivity, followed by a
confirmatory test of high specificity are used [22]. Generally, c-ELISAs are more specific than i-ELISAs
but less sensitive [23]. Sensitivities and specificities of ELISAs were evaluated previously showed that
100% sensitivity and specificity were found for c-ELISAs, and i-ELISA showed 99.1% specificity and
100% sensitivity, respectively [24]. c-ELISAs proved to be highly sensitive and specific when compared
to other commonly used serological tests, i.e., Rose Bengal test, fluorescence polarization assay, i-ELISA
for diagnosis of swine brucellosis [25].
Although confirmation of the disease is achieved by bacterial culture and isolation of the etiological
agent, Brucella is difficult to grow and bacterial culturing and biochemical identification are time
consuming. Additionally, this method poses risk to laboratory personnel and requires specific biosafety
measures [26]. Hence, detection of DNA by PCR in clinical samples is considered a preferred tool for
definitive diagnosis of brucellosis [27].
Although brucellosis in pigs has not been noted in Egyptian surveillance reports, a Rose Bengal
plate agglutination assay (RBPT) was performed previously to quantify the risk for workers in
slaughterhouses [15].
Considering public health concerns and the zoonotic importance of brucellosis, the present study
was aimed to identify seropositive pigs at slaughterhouses and to characterize subsequently the Brucella
species involved in swine brucellosis in Egypt.
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2. Materials and Methods
2.1. Study Area and Sera Collection
The study was conducted from March 2017 to July 2019. The serum samples were collected from
abattoirs of Cairo and Giza governorates in Egypt. The data for each sample including origin, sex,
and date of sampling were recorded. In total, 331 blood samples (116 from males and 215 from females)
were collected in sterile vacutainer tubes without anticoagulant. The serum was harvested and stored
at −20 ◦C. The serum was shipped to Friedrich–Loeﬄer Institut, Jena, Germany for further analysis.
2.2. Ethics Statement
This study was carried out in strict accordance with the recommendations in the Guide of the
Egyptian Network of Research Ethics Committees (ENREC), which complies with the international
laws and regulation regarding ethical considerations in research. All efforts were made to minimize
animal suffering and to reduce the number of animals used.
2.3. Detection of Anti-Brucella Antibodies
Antibody detection was carried out using the IDVet indirect ELISA kit (ID Screen® Brucellosis
Serum Indirect Multi-species) (IDVet Innovative Diagnostics Grabels, France) and the SVANOVIR®
Brucella-Ab c-ELISA kit (Uppsala, Sweden) according to the manufacturer’s instructions.
2.4. Molecular Detection of Brucella DNA
DNA was extracted from all collected serum samples by using the QIAamp DNA Mini Kit
(QIAGEN, Germany) according to the instructions of the manufacturer.
Genus- (Brucella) and species-specific (B. abortus, B. melitensis, and B. suis) multiplex real-time PCRs
were used for detection of Brucella DNA. PCR was performed using the primer and probe sets given in
Table 1 (Jena Bioscience GmbH, Germany). Briefly, the PCR reaction was done in a 15 µL multiplex PCR
mixture with 2× TaqMan™ Environmental master mix (Applied Biosystems®, Germany), 0.2 µM of
each primer, 0.1 µM of each probe, and 5 µL of template DNA. Amplification and real-time fluorescence
detection was carried out on a StepOnePlus™ Real-Time PCR System (Applied Biosystems®, Germany).
The reaction conditions were decontamination at 50 ◦C for 2 min, initial denaturation at 95 ◦C for
10 min followed by 50 cycles of denaturing at 95 ◦C for 25 s and annealing/elongation at 60 ◦C for 1 min.
Sample data scores were confirmed by visual inspection of graphical plots and cycle threshold (CT)
values for each sample were obtained. CT values below 38 were considered positive. Reference strains
of B. abortus S-99 (ATCC 23448), B. melitensis 16M (ATCC 23456), and B. suis biovar 1 (ATCC 23444) were
used as positive controls for each PCR reaction to ensure no cross-contamination.
Table 1. Primer and probe sequences used in real-time multiplex PCR assay for the detection ofBrucella spp.,
B. abortus, B. melitensis, and B. suis.
Target Primer sequences Reference
Brucella
5’-GCT CGG TTG CCA ATA TCA ATG C-3′
5′-GGG TAA AGC GTC GCC AGA AG-3′





5′-GCG GCT TTT CTA CGG TAT TC-3′
5′-CAT GCG CTA TGA TCT GGT TAC G-3′





5′-AAC AAG CGG CAC CCC TAA AA-3′
5′-CAT GCG CTA TGA TCT GGT TAC G-3′





5′-GCC AAA TAT CCA TGC GGG AAG-3′
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3. Results
3.1. Anti-Brucella Antibodies in Pig Sera
Out of 331 sera samples, 16 (4.83%) were positive for anti-Brucella antibodies by i-ELISA and
36 (10.8%) were positive by c-ELISA. In the Cairo governorate, 1.21% and 9.75% sera were positive
while, in the Giza governorate, 6.02% and 11.2% were positive by i-ELISA and c-ELISA, respectively.
Anti-Brucella antibodies were detected in 12.9% and 21.5% of boars by i-ELISA and c-ELISA, respectively.
Only 1 (0.46%) female animal was seropositive by i-ELISA while 5.11% were positive by c-ELISA
(Table 2). Only three sera samples were positive with both ELISAs.
Table 2. Seroprevalence and molecular identification of Brucella-DNA in pig sera collected from Cairo




























Total 331 16 (4.83) 36 (10.8) 10 (3.02)
3.2. Detection of Brucella DNA in Pig Sera
Brucella-specific DNA was detected in 10 (3.02%) samples and typed as B. melitensis (7/10) and
B. suis (3/10) (Table 2). In Cairo, 3.65% sera were positive, and in Giza it was 2.81%. In 6.03% boars
Brucella-specific DNA was detected, in female pigs it was 1.39%. Boars originating from Giza governorate
were more often positive (11.7%) than those from the Cairo governorate (3.65%). Only three sera were
positive with all tested assays, while Brucella DNA was detected in all c-ELISA positive serum samples.
4. Discussion
This study is the first investigation of swine brucellosis using serological and molecular tools in
Egypt. Despite the endemicity of Brucella infection in humans and ruminants for many years [7], pig
brucellosis has never been reported. Many published studies highlighted the identification of Brucella
in various animal species (cattle, buffalo, sheep, goat, bison, African buffalo and Alpine ibex) to define
their potential role in disease spread [30–33]. The pigs investigated in this study were raised in slums,
rural, and per-urban areas likely having close contact with other livestock (cattle, sheep, and goats)
which may lead to sharing of pathogens with each other as described previously in Egypt [15].
Swine brucellosis is a zoonotic disease and is widely prevalent in many pig-rearing countries [16].
The proof of the existence of swine brucellosis in Egypt may now raise awareness and can help to tailor
control strategies to improve human health.
Brucellosis is diagnosed usually by using serological screening tests of high sensitivity followed
by highly specific tests due to the false–positive reactions which probably arise from cross-reactions
with other bacteria and mainly with Yersinia enterocolitica O:9. Swine serum may sometimes contain
nonspecific antibodies, probably IgM, that reduce the specificity of conventional tests, especially for
serum agglutination tests. Moreover, the swine complement interacts with the guinea-pig complement
to produce pro-complementary activity that reduces the sensitivity of the complement fixation test
(CFT) [2]. The c-ELISA is more sensitive and specific in swine brucellosis serology [25]. Both serological
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tests applied showed different results. Previous studies on pig brucellosis found 100% sensitivity and
specificity for c-ELISA, and 99.1% specificity and 100% sensitivity for the i-ELISA, respectively [24].
In this study, 331 samples of pigs collected at slaughterhouses of Cairo and Giza governorates
that have the highest swine populations in Egypt were investigated. A higher number of seropositive
pigs was recorded by c-ELISA (10.8%) when compared to the i-ELISA (4.83%). Although these samples
were not taken following the sampling plan of the Egyptian prevalence study plan of ruminants,
the ranges are in agreement with the previous prevalence reports of brucellosis in cattle, buffaloes,
sheep, and goats in Egypt [7,10,34].
Quantitative real-time PCR for Brucella DNA detection has proved highly specific and sensitive
when compared to other conventional PCR assays and serology [35]. In the current study, Brucella DNA
was detected in 3.02% of pig samples. Qualitative multiplex real-time PCR confirmed seven B. melitensis
and three B. suis DNAs. Detection of B. melitensis DNA in the present study in pigs reared in Cairo and
Giza governorates was expected as previous reports showed the endemicity of B. melitensis in these
regions in Egypt [7]. The identification of B. suis in this study is not unexpected as B. suis was previously
isolated from cattle [6] ensuring the presence of these species in Egypt. The detection of a higher
number of B. melitensis DNA samples as compared to B. suis DNA in this study is expected as these
pigs are in close contact with free grazing sheep and goat flocks. It is common in extensive livestock
farming to share pastures and watering. Such type of mixing of animals is an important risk factor to
spread the disease from infected to healthy animals or other livestock species [36]. Most sheep and
goat flocks are mobile in Egypt. Movements of infected animals can contaminate feeding and grazing
areas and may spread infection to other animals (e.g., cattle, buffalo or camel) [10]. The prevalence of
B. melitensis and B. suis in swine may be attributed to the cross-contamination or co-rearing of pigs
with other animals [6,15,19,20].
In this study, Brucella DNA was detected in 10 (3.02%) of the seropositive samples. Out of
10 positive DNAs, three samples were found positive with both ELISAs (i-ELISA and c-ELISA), while
seven DNAs were found positive in samples which were only positive with c-ELISA. The higher
number of Brucella DNA was identified in c-ELISA positives sera. It was proven that c-ELISA has
shown higher sensitivities and specificities for the diagnosis of swine brucellosis [25].
Sex dependent prevalence has been documented in cattle and small ruminants, i.e., B. melitensis is
more often found in females. Hence, this phenomenon in pigs has not fully been investigated, it may
affect both sexes (male and female) equally [37]. In this study, higher prevalence was found in male
pigs than in female pigs. Significantly higher molecular prevalence of brucellosis in males (27.7%)
than in females (8.09%) were previously reported from India [21]. Higher prevalence of anti-Brucella
antibodies in boars was reported also 11.11% vs 3.29% from Nepal, previously [38].
The endemic nature of the disease, particularly the identification of B. melitensis and B. suis DNA
from swine sera suggests a complex underlying epidemilogical situation in Egypt.
5. Conclusions
To the best of our knowledge, this is the first study reporting the presence of anti-Brucella antibodies
and Brucella DNA in serum collected from pigs in Egypt. This study, although performed on a limited
number of samples and focusing on two governorates only, gives an insight on the situation of
brucellosis and Brucella species prevalent in pigs in Egypt. As the investigated pigs in this study were
apparently healthy and admitted for slaughtering, we believe that pigs can be carriers of brucellosis and
present a risk to livestock or even humans or may act as a dead-end host, unlikely to be involved in the
transmission. Further investigation is needed to assess the prevalence of Brucella species particularly
B. suis in swine to explore the ways of cross-contamination and the risk for consumers.
Author Contributions: Data curation, A.U.K., S.A.G.E.E.-S, S.A.M., M.A.S.A. and H.E.-A.; Investigation, A.U.K.,
H.E.-A. and F.M.; Methodology, A.U.K., F.M. and H.E.-A.; Resources, H.E.-A.; Supervision, F.M., M.E., U.R., H.N.
and H.E.-A.; Writing – original draft, A.U.K., F.M. and H.E.-A.; Writing – review & editing, F.M., M.C.E., U.R.,
H.N. and H.E.-A.
Pathogens 2019, 8, 248 6 of 7
Funding: This research received no external funding.
Acknowledgments: The authors thank Michaela Ganss and Katja Fischer at the Institute of Bacterial Infections
and Zoonoses, Friedrich–Loeﬄer Institut (FLI) for their cooperation and technical assistance. This research work
was supported by the International Research Project as part of the “German Biosecurity Program” funded by the
Federal Foreign Office, Germany. The authors thank Islamic Development Bank (IDB), Jeddah, Saudi Arabia for
PhD grant.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. El-Sayed, A.; Awad, W. Brucellosis: Evolution and expected comeback. Int. J. Vet. Sci. Med. 2018, 6, 31–35.
[CrossRef] [PubMed]
2. OIE. Brucellosis (Brucella abortus, B. melitensis and B. suis) (infection with B. abortus, B. melitensis and B. suis).
In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2019, OIE; World Health Organization for
Animal Health: Paris, France, 2019; pp. 355–398.
3. Kirk, M.D.; Pires, S.M.; Black, R.E.; Caipo, M.; Crump, J.A.; Devleesschauwer, B.; Dopfer, D.; Fazil, A.;
Fischer-Walker, C.L.; Hald, T.; et al. World health organization estimates of the global and regional disease
burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: A data synthesis. PLoS Med. 2015,
12, e1001921.
4. Hosein, H.I.; Zaki, H.M.; Safwat, N.M.; Menshawy, A.M.S.; Rouby, S.; Mahrous, A.; Madkour, B.E. Evaluation
of the general organization of veterinary services control program of animal brucellosis in egypt: An outbreak
investigation of brucellosis in buffalo. Vet. World 2018, 11, 9. [CrossRef] [PubMed]
5. Refai, M. Incidence and control of brucellosis in the near east region. Vet. Microbiol. 2002, 90, 81–110. [CrossRef]
6. Menshawy, A.M.; Perez-Sancho, M.; Garcia-Seco, T.; Hosein, H.I.; Garcia, N.; Martinez, I.; Sayour, A.E.;
Goyache, J.; Azzam, R.A.; Dominguez, L.; et al. Assessment of genetic diversity of zoonotic brucella spp.
Recovered from livestock in egypt using multiple locus vntr analysis. BioMed Res. Int. 2014, 2014, 353876.
[CrossRef] [PubMed]
7. Wareth, G.; Hikal, A.; Refai, M.; Melzer, F.; Roesler, U.; Neubauer, H. Animal brucellosis in egypt. J. Infect.
Dev. Ctries. 2014, 8, 1365–1373. [CrossRef]
8. Hegazy, Y.M.; Molina-Flores, B.; Shafik, H.; Ridler, A.L.; Guitian, F.J. Ruminant brucellosis in upper egypt
(2005–2008). Prev. Vet. Med. 2011, 101, 9. [CrossRef]
9. Eltholth, M.M.; Hegazy, Y.M.; El-Tras, W.F.; Bruce, M.; Rushton, J. Temporal analysis and costs of ruminant
brucellosis control programme in egypt between 1999 and 2011. Transbound. Emerg. Dis. 2017, 64, 1191–1199.
[CrossRef]
10. Samaha, H.; Al-Rowaily, M.; Khoudair, R.M.; Ashour, H.M. Multicenter study of brucellosis in egypt. Emerg.
Infect. Dis. 2008, 14, 1916–1918. [CrossRef]
11. Zakaria, A.M.; Ahmed, S.F.; Motawae, M.S. Seropositivity in animals and risk of occupational brucellosis
among abattoirs personnel associated with poor work practices and absence of safety policy in egypt. Int. J.
Occup. Environ. Health 2018, 24, 55–60. [CrossRef]
12. Lassaletta, L.; Estelles, F.; Beusen, A.H.W.; Bouwman, L.; Calvet, S.; van Grinsven, H.J.M.; Doelman, J.C.;
Stehfest, E.; Uwizeye, A.; Westhoek, H. Future global pig production systems according to the shared
socioeconomic pathways. Sci. Total Environ. 2019, 665, 739–751. [CrossRef]
13. Abdelwhab, E.M.; Abdel-Moneim, A.S. Epidemiology, ecology and gene pool of influenza a virus in egypt:
Will egypt be the epicentre of the next influenza pandemic? Virulence 2015, 6, 6–18. [CrossRef]
14. Gomaa, M.R.; Kandeil, A.; El-Shesheny, R.; Shehata, M.M.; McKenzie, P.P.; Webby, R.J.; Ali, M.A.; Kayali, G.
Evidence of infection with avian, human, and swine influenza viruses in pigs in cairo, egypt. Arch. Virol.
2018, 163, 359–364. [CrossRef]
15. Ashraf, M.B.; Hassan, A.; Raafat, M.; Fathia, A.M. Occupational health hazard of egyptian employees in
contact with wastage nourished swine. J. Am. Sci. 2011, 7, 6.
16. Olsen, S.C.; Tatum, F.M. Swine brucellosis: Current perspectives. Vet. Med. 2017, 8, 1–12. [CrossRef]
17. Nagalingam, M.; Shome, R.; Balamurugan, V.; Shome, B.R.; NarayanaRao, K.; Vivekananda; Isloor, S.;
Prabhudas, K. Molecular typing of brucella species isolates from livestock and human. Trop. Anim. Health Prod.
2012, 44, 5–9. [CrossRef]
Pathogens 2019, 8, 248 7 of 7
18. Higgins, J.; Stuber, T.; Quance, C.; Edwards, W.H.; Tiller, R.V.; Linfield, T.; Rhyan, J.; Berte, A.; Harris, B.
Molecular epidemiology of Brucella abortus isolates from cattle, elk, and bison in the united states, 1998 to
2011. Appl. Environ. Microbiol. 2012, 78, 10. [CrossRef]
19. Lucero, N.E.; Ayala, S.M.; Escobar, G.I.; Jacob, N.R. Brucella isolated in humans and animals in latin america
from 1968 to 2006. Epidemiol. Infect. 2008, 136, 496–503. [CrossRef]
20. De Massis, F.; Zilli, K.; Di Donato, G.; Nuvoloni, R.; Pelini, S.; Sacchini, L.; D’Alterio, N.; Di Giannatale, E.
Distribution of brucella field strains isolated from livestock, wildlife populations, and humans in italy from
2007 to 2015. PLoS ONE 2019, 14, 16. [CrossRef]
21. Shome, R.; Kalleshamurthy, T.; Natesan, K.; Jayaprakash, K.R.; Byrareddy, K.; Mohandoss, N.; Sahay, S.;
Shome, B.R.; Hiremath, J.; Rahman, H.; et al. Serological and molecular analysis for brucellosis in selected
swine herds from southern india. J. Infect. Public Health 2019, 12, 247–251. [CrossRef]
22. Nielsen, K.; Yu, W.L. Serological diagnosis of brucellosis. Prilozi 2010, 31, 65–89.
23. Godfroid, J.; Nielsen, K.; Saegerman, C. Diagnosis of brucellosis in livestock and wildlife. Croat. Med. J. 2010,
51, 296–305. [CrossRef] [PubMed]
24. Di Febo, T.; Luciani, M.; Portanti, O.; Bonfini, B.; Lelli, R.; Tittarelli, M. Development and evaluation of
diagnostic tests for the serological diagnosis of brucellosis in swine. Vet. Ital. 2012, 48, 133–156. [PubMed]
25. Praud, A.; Gimenez, O.; Zanella, G.; Pozzi, N.; Antras, V.; Meyer, L.; Garin-Bastuji, B. Evaluation of five
serological tests for the diagnosis of porcine brucellosis in french polynesia. Trop. Anim. Health Prod. 2013,
45, 931–933. [CrossRef] [PubMed]
26. Mathew, C.; Stokstad, M.; Johansen, T.B.; Klevar, S.; Mdegela, R.H.; Mwamengele, G.; Michel, P.;
Escobar, L.; Fretin, D.; Godfroid, J. First isolation, identification, phenotypic and genotypic characterization
of brucella abortus biovar 3 from dairy cattle in tanzania. BMC Vet. Res. 2015, 11, 9. [CrossRef] [PubMed]
27. Ulu-Kilic, A.; Metan, G.; Alp, E. Clinical presentations and diagnosis of brucellosis. Recent Pat. Anti Infect.
Drug Discov. 2013, 8, 34–41. [CrossRef]
28. Probert, W.S.; Schrader, K.N.; Khuong, N.Y.; Bystrom, S.L.; Graves, M.H. Real-time multiplex pcr assay for
detection of brucella spp., B. Abortus, and B. Melitensis. J. Clin. Microbiol. 2004, 42, 1290–1293. [CrossRef]
29. Hansel, C.; Mertens, K.; Elschner, M.C.; Melzer, F. Novel real-time pcr detection assay for Brucella suis.
Vet. Rec. Open 2015, 2, 7. [CrossRef]
30. Sanogo, M.; Abatih, E.; Thys, E.; Fretin, D.; Berkvens, D.; Saegerman, C. Importance of identification and
typing of brucellae from west african cattle: A review. Vet. Microbiol. 2013, 164, 202–211. [CrossRef]
31. Godfroid, J.; Al Dahouk, S.; Pappas, G.; Roth, F.; Matope, G.; Muma, J.; Marcotty, T.; Pfeiffer, D.; Skjerve, E.
A “one health” surveillance and control of brucellosis in developing countries: Moving away from
improvisation. Comp. Immunol. Microbiol. Infect. Dis. 2013, 36, 8. [CrossRef]
32. Machavarapu, M.; Poonati, R.; Mallepaddi, P.C.; Gundlamadugu, V.; Raghavendra, S.; Polavarapu, K.K.B.;
Polavarapu, R. Endemic brucellosis in indian animal and human populations: A billion dollar issue. J. Curr.
Trends Biotechnol. Pharm. 2019, 13, 112–123.
33. Godfroid, J. Brucellosis in livestock and wildlife: Zoonotic diseases without pandemic potential in need of
innovative one health approaches. Arch. Public Health 2017, 75, 34. [CrossRef] [PubMed]
34. El-Hady, A.M.; Sayed-Ahmed, M.; Saleh, M.E.; Younis, E.E. Seroprevalence and molecular epidemiology of
brucellosis in cattle in egypt. Adv. Dairy Res. 2016, 4, 1–4. [CrossRef]
35. Al-Ajlan, H.H.; Ibrahim, A.S.; Al-Salamah, A.A. Comparison of different pcr methods for detection of
brucella spp. In human blood samples. Pol. J. Microbiol. 2011, 60, 27–33. [CrossRef] [PubMed]
36. Diaz Aparicio, E. Epidemiology of brucellosis in domestic animals caused by brucella melitensis, brucella
suis and brucella abortus. Rev. Sci. Tech. 2013, 32, 53–60. [CrossRef]
37. Coelho, A.C.; Díez, J.G.; Coelho, A.M. Risk factors for brucella spp. In domestic and wild animals. In Updates
on Brucellosis; Intech Open: London, UK, 2015.
38. Sharma, S.; Khanal, D.R.; Panth, Y. Seroprevalence of brucellosis in pigs of bhaktapur, kavre and banke
districts of nepal. Int. J. Appl. Sci. Biotechnol. 2017, 5, 466–469. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
